Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
COVID-19
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
COVID-19
Webinars

Skip Nav Destination

Issues

Select Year

Issue

Volume 4, Issue 1

1 January 1998

Front Matter
Table of Contents
Back Matter
Editorial Board

ISSN 1078-0432

EISSN 1557-3265

Issue Sections

Minireview
Advances in Brief
Research Articles
Letter to the Editor

Minireview

The role of DNA mismatch repair in drug resistance.

D Fink; S Aebi; S B Howell

Advances in Brief

HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.

R M Elledge; S Green; D Ciocca; R Pugh; D C Allred; G M Clark; J Hill; P Ravdin; J O'Sullivan; S Martino; C K Osborne

Research Articles

Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma.

J Rubin Grandis; D J Tweardy; M F Melhem

CD44 expression in the stromal matrix of colorectal cancer: association with prognosis.

K Furuta; M Zahurak; S N Goodman; S R Hamilton; J T August

Expression of intercellular adhesion molecule-1 in invasive breast cancer reflects low growth potential, negative lymph node involvement, and good prognosis.

Y Ogawa; K Hirakawa; B Nakata; T Fujihara; T Sawada; Y Kato; K Yoshikawa; M Sowa

Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal.

N Dawson; W D Figg; O W Brawley; R Bergan; M R Cooper; A Senderowicz; D Headlee; S M Steinberg; M Sutherland; N Patronas; E Sausville; W M Linehan; E Reed; O Sartor

Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a phase I/II study in pediatric patients with relapsed leukemias. The Children's Cancer Group.

V I Avramis; S Wiersma; M D Krailo; L V Ramilo-Torno; A Sharpe; W Liu-Mares; R Kowck; G H Reaman; J K Sato

A phase I and pharmacokinetic study of tallimustine [PNU 152241 (FCE 24517)] in patients with advanced cancer.

G R Weiss; I Poggesi; M Rocchetti; D DeMaria; T Mooneyham; D Reilly; L V Vitek; F Whaley; E Patricia; D D Von Hoff; P O'Dwyer

Treatment of metastatic bone pain with tin-117m Stannic diethylenetriaminepentaacetic acid: a phase I/II clinical study.

S C Srivastava; H L Atkins; G T Krishnamurthy; I Zanzi; E B Silberstein; G Meinken; L F Mausner; F Swailem; T D'Alessandro; C J Cabahug; Y Lau; T Park; S Madajewicz

Cranial irradiation and permeability of blood-brain barrier to cytosine arabinoside in children with acute leukemia.

R Riccardi; A Riccardi; A Lasorella; T Servidei; S Mastrangelo

Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma.

E Bajetta; M Del Vecchio; R Mortarini; R Nadeau; A Rakhit; L Rimassa; C Fowst; A Borri; A Anichini; G Parmiani

Apoptotic tumor cell death induced by estramustine in patients with malignant glioma.

C Vallbo; A T Bergenheim; P Bergström; P O Gunnarsson; R Henriksson

Detection of germ cell tumor cells in apheresis products using polymerase chain reaction.

Y Fan; L Einhorn; S Saxman; B Katz; R Abonour; K Cornetta

Preclinical evaluation of 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine-mediated radiosensitization in mouse and human tissues.

T J Kinsella; K A Kunugi; K A Vielhuber; D M Potter; M E Fitzsimmons; J M Collins

Doxorubicin entrapped in sterically stabilized liposomes: effects on bacterial blood clearance capacity of the mononuclear phagocyte system.

G Storm; M T ten Kate; P K Working; I A Bakker-Woudenberg

6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin.

I I Budihardjo; D L Walker; P A Svingen; C A Buckwalter; S Desnoyers; S Eckdahl; G M Shah; G G Poirier; J M Reid; M M Ames; S H Kaufmann

Characterization of 5-oxo-L-prolinase in normal and tumor tissues of humans and rats: a potential new target for biochemical modulation of glutathione.

X Chen; R L Schecter; O W Griffith; M A Hayward; L C Alpert; G Batist

Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine.

X Gao; J L Au; R A Badalament; M G Wientjes

Selective sensitization to DNA-damaging agents in a human rhabdomyosarcoma cell line with inducible wild-type p53 overexpression.

A A Gibson; F G Harwood; D M Tillman; J A Houghton

Modulation of cancer chemotherapy by green tea.

Y Sadzuka; T Sugiyama; S Hirota

A sensitive and specific radioimmunoassay for LY309887, a potent inhibitor of glycinamide ribonucleotide formyltransferase.

D L Coleman; N Canak; G D Place; C Shih; R R Bowsher

In vivo toxicity and pharmacokinetic features of B43 (anti-CD19)-genistein immunoconjugate in nonhuman primates.

Y Messinger; Y Yanishevski; O Ek; T Zeren; B Waurzyniak; R Gunther; L Chelstrom; M Chandan-Langlie; E Schneider; D E Myers; W Evans; F M Uckun

Antitumor activity of actinonin in vitro and in vivo.

Y Xu; L T Lai; J L Gabrilove; D A Scheinberg

Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis.

S J Kim; E Shiba; T Kobayashi; E Yayoi; J Furukawa; Y Takatsuka; E Shin; H Koyama; H Inaji; S Takai

Translocations involving chromosome 12p11-13, methotrexate metabolism, and outcome in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.

V M Whitehead; M J Vuchich; L Cooley; S J Lauer; D H Mahoney; J J Shuster; C Payment; M L Bernstein; J J Akabutu; T Bowen; B A Kamen; M S Watson; A T Look; D J Pullen; B Camitta

Prognostic value of p53 and urokinase-type plasminogen activator in node-negative human breast cancers.

J P Peyrat; L Vanlemmens; J Fournier; G Huet; F Révillion; J Bonneterre

Genetic changes and telomerase activity in human renal cell carcinoma.

V Rohde; H P Sattler; B Oehlenschläger; S Forster; T Zwergel; G Seitz; B Wullich

TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival.

A L Børresen-Dale; R A Lothe; G I Meling; P Hainaut; T O Rognum; E Skovlund

Genetic abnormalities in parathyroid nodules of uremic patients.

J Chudek; E Ritz; G Kovacs

Gene amplification as a prognostic factor in primary brain tumors.

J J Olson; D Barnett; J Yang; R Assietti; G Cotsonis; C D James

RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features.

I Bongarzone; P Vigneri; L Mariani; P Collini; S Pilotti; M A Pierotti

Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma.

K Yashima; S Milchgrub; L S Gollahon; A Maitra; M H Saboorian; J W Shay; A F Gazdar

Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1.

H Aida; K Takakuwa; H Nagata; I Tsuneki; M Takano; S Tsuji; T Takahashi; T Sonoda; M Hatae; K Takahashi; K Hasegawa; H Mizunuma; N Toyoda; H Kamata; Y Torii; N Saito; M Yakushiji; T Araki; K Tanaka

Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.

G Fontanini; M De Laurentiis; S Vignati; S Chinè; M Lucchi; V Silvestri; A Mussi; S De Placido; G Tortora; A R Bianco; W Gullick; C A Angeletti; G Bevilacqua; F Ciardiello

Bypass of abnormal MDM2 inhibition of p53-dependent growth suppression.

R D Meng; H Shih; N S Prabhu; D L George; W S el-Deiry

Letter to the Editor

Correspondence Re: C. Caserini et al., Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies. Clin. Cancer Res., 3: 955-961, 1997.

V R Bulusu

Advertisement

Email alerts

Online First Alert

eTOC Alert

Latest
Most Read
Most Cited

Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas

Biology and Targetability of the Extended Spectrum of PIK3CA Mutations Detected in Breast Carcinoma

T cell receptor repertoire sequencing in the era of cancer immunotherapy

HER2 copy number and resistance mechanisms in patients with HER2-positive advanced gastric cancer receiving initial trastuzumab-based therapy in JACOB trial

Issues
Online First
Collections

News
Twitter

Online ISSN 1557-3265
Print ISSN 1078-0432

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers, & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Info for Advertisers
Info for Librarians
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2022 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept